EDTA Chelation Therapy for the Treatment of Neurotoxicity

28Citations
Citations of this article
130Readers
Mendeley users who have this article in their library.

Abstract

Neurotoxicity can be caused by numerous direct agents, of which toxic metals, organophosphorus pesticides, air pollution, radiation and electromagnetic fields, neurotoxins, chemotherapeutic and anesthetic drugs, and pathogens are the most important. Other indirect causes of neurotoxicity are cytokine and/or reactive oxygen species production and adoptive immunotherapy. The development of neurodegenerative diseases has been associated with neurotoxicity. Which arms are useful to prevent or eliminate neurotoxicity? The chelating agent calcium disodium ethylenediaminetetraacetic acid (EDTA)-previously used to treat cardiovascular diseases-is known to be useful for the treatment of neurodegenerative diseases. This review describes how EDTA functions as a therapeutic agent for these diseases. Some case studies are reported to confirm our findings.

Cite

CITATION STYLE

APA

Fulgenzi, A., & Ferrero, M. E. (2019, February 26). EDTA Chelation Therapy for the Treatment of Neurotoxicity. International Journal of Molecular Sciences. NLM (Medline). https://doi.org/10.3390/ijms20051019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free